303 related articles for article (PubMed ID: 12552038)
1. APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
Tsuboi Y; Josephs KA; Cookson N; Dickson DW
Neurology; 2003 Jan; 60(2):240-5. PubMed ID: 12552038
[TBL] [Abstract][Full Text] [Related]
2. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
3. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy.
Tabaton M; Rolleri M; Masturzo P; Cammarata S; Angelini G; Hansen LA; Saitoh T; Petersen RB; Perry G; Richey P
Neurology; 1995 Sep; 45(9):1764-5. PubMed ID: 7675243
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration.
Josephs KA; Tsuboi Y; Cookson N; Watt H; Dickson DW
Arch Neurol; 2004 Oct; 61(10):1579-84. PubMed ID: 15477512
[TBL] [Abstract][Full Text] [Related]
6. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
8. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
10. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles.
Kazama H; Ruberu NN; Murayama S; Saito Y; Nakahara K; Kanemaru K; Nagura H; Arai T; Sawabe M; Yamanouchi H; Orimo H; Hosoi T
Dement Geriatr Cogn Disord; 2004; 18(2):145-50. PubMed ID: 15211069
[TBL] [Abstract][Full Text] [Related]
11. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
[TBL] [Abstract][Full Text] [Related]
13. Assessment of APOE in atypical parkinsonism syndromes.
Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
[TBL] [Abstract][Full Text] [Related]
14. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue.
Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I
Dement Geriatr Cogn Disord; 1999; 10(4):252-7. PubMed ID: 10364641
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
16. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
17. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
18. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
[TBL] [Abstract][Full Text] [Related]
19. Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.
Oshima K; Dickson DW
Int J Clin Exp Pathol; 2009; 2(4):399-406. PubMed ID: 19158937
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG; Scharnagl H; März W; Bohl J
Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
